Bell Bank’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,817
Closed -$91K 153
2020
Q1
$91K Buy
16,817
+105
+0.6% +$938 0.02% 141
2019
Q4
$151K Buy
16,712
+247
+2% +$2.01K 0.03% 156
2019
Q3
$118K Sell
16,465
-182
-1% -$1.31K 0.02% 158
2019
Q2
$132K Sell
16,647
-551
-3% -$6.52K 0.03% 154
2019
Q1
$216K Sell
17,198
-683
-4% -$10.8K 0.06% 136
2018
Q4
$357K Buy
17,881
+5,054
+39% +$117K 0.11% 111
2018
Q3
$364K Buy
12,827
+2,511
+24% +$59.9K 0.11% 115
2018
Q2
$217K Buy
+10,316
New +$195K 0.07% 141

Other funds holding EVH

Bell Bank's EVH Position: Q2 2020 in Review

Bell Bank sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 16,817 shares — an estimated $91K sold.

Bell Bank first reported a position in EVH in Q2 2018 and held it in 8 quarters. The position peaked at $364K in Q3 2018. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Bell Bank reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Bell Bank sold 16,817 Evolent Health shares in Q2 2020, an estimated $91K.
  • Bell Bank first reported a position in Evolent Health in Q2 2018 and held it in 8 quarters.
  • Bell Bank's Evolent Health position peaked at $364K in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Bell Bank's 13F filing for Q2 2020, filed 13 Aug 2020.